Elisabetta Gerratana Selected Research

Elisabetta Gerratana Research Topics

4	Rheumatoid Arthritis 06/2021 - 11/2018
4	Inflammation (Inflammations) 01/2021 - 01/2020
2	COVID-19 02/2021 - 01/2021
2	Rheumatic Diseases (Rheumatism) 02/2021 - 01/2020
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2021 - 01/2021
2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 01/2021
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2020
2	Arthritis (Polyarthritis) 08/2020 - 04/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021
1	Psoriatic Arthritis 01/2021
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Cytokine Release Syndrome 01/2021
1	Axial Spondyloarthritis 08/2020
1	Atherosclerosis 06/2020
1	Cardiovascular Infections 06/2020
1	Infections 06/2020
1	Obesity 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2020

3	Antirheumatic Agents (DMARD)IBA 01/2021 - 04/2020
2	baricitinibIBA 02/2021 - 01/2021
2	Synthetic DrugsIBA 01/2021 - 11/2018
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2021 - 01/2021
1	Biosimilar PharmaceuticalsIBA 06/2021
1	Etanercept (Enbrel)FDA Link 06/2021
1	Antimalarials (Antimalarial Agents)IBA 02/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2021
1	Colchicine FDA LinkGeneric 02/2021
1	Immunomodulating AgentsIBA 02/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	InterleukinsIBA 01/2021
1	Interleukin-6 InhibitorsIBA 01/2021
1	nintedanibIBA 01/2021
1	pirfenidoneIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2020
1	Tumor Necrosis Factor InhibitorsIBA 08/2020
1	Methotrexate (Mexate)FDA LinkGeneric 08/2020
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 08/2020
1	AntibodiesIBA 06/2020
1	LipidsIBA 06/2020
1	CoagulantsIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	AutoantibodiesIBA 01/2020
1	Janus Kinase InhibitorsIBA 11/2018
1	Janus KinasesIBA 11/2018